{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:31:16Z","timestamp":1759797076861,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijrobp.2022.07.1833","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:51:15Z","timestamp":1672977075000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy."],"prefix":"10.1016","volume":"115","author":[{"given":"Matthew","family":"Harkenrider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Damast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-9685","authenticated-orcid":false,"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0001","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s42003-021-01741-x","article-title":"Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation","volume":"4","author":"Sims","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0003","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.prro.2022.03.013","article-title":"Longitudinal changes in bone mineral measurements inside and outside radiation fields used for cervical cancer treatment","volume":"12","author":"Wu","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PGP.0000000000000806","article-title":"Defining substantial lymphovascular space invasion in endometrial cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0362","article-title":"Quality-of-life outcomes and toxic effects among patients with cancers of the uterus treated with stereotactic pelvic adjuvant radiation therapy: The spartacus phase 1\/2 nonrandomized controlled trial","volume":"8","author":"Leung","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0006","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamaoncol.2019.3857","article-title":"Sequential ipilimumab after chemoradiotherapy in curative-intent treatment of patients with node-positive cervical cancer","volume":"6","author":"Mayadev","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0007","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1002\/cncr.33136","article-title":"Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer","volume":"126","author":"Duska","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247905","article-title":"A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers","volume":"16","author":"El Alam","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2019.12.040","article-title":"Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer","volume":"107","author":"Mitra","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0012","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.32807","article-title":"Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women","volume":"126","author":"Salcedo","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0013","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO Gyn working group and the EMBRACE studies","volume":"9","author":"Potter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for Stage Ib-IVa cervical cancer: An international multicenter Phase II clinical trial (INTERTECC-2)","volume":"97","author":"Mell","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2021.09.009","article-title":"Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: A systematic review","volume":"164","author":"Corbeau","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijrobp.2019.09.012","article-title":"Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: A meta-analysis and meta-regression of 3929 patients","volume":"106","author":"Sapienza","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0017","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.294.20.2587","article-title":"Risk of pelvic fractures in older women following pelvic irradiation","volume":"294","author":"Baxter","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0018","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2022.07.008","article-title":"Serial bone density changes in women undergoing pelvic (chemo) radiation: Results from PARCER trial","volume":"114","author":"Chopade","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: A gynecologic oncology group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: An independent prognostic factor in endometrial cancer","volume":"96","author":"Briet","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0023","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish gynecologic cancer group (SWEGCG) study","volume":"58","author":"Stalberg","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0024","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0025","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7","article-title":"The grading of lymphovascular space invasion in endometrial carcinoma","volume":"86","author":"Hachisuga","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0026","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0027","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized Polish II study","volume":"30","author":"Cisel","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - results of the international randomized RAPIDO-trial","volume":"147","author":"van der Valk","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0029","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2018.07.2005","article-title":"Phase 1-2 study of stereotactic ablative radiotherapy including regional lymph node irradiation in patients with high-risk prostate cancer (SATURN): Early toxicity and quality of life","volume":"102","author":"Musunuru","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.08.017","article-title":"Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials","volume":"163","author":"Glicksman","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0031","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3857\/roj.2013.31.4.216","article-title":"Short-course palliative radiotherapy for uterine cervical cancer","volume":"31","author":"Kim","year":"2013","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0032","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (fast-forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0260","article-title":"Are we finally ready for the widespread adoption of stereotactic radiation in gynecologic cancers?","volume":"8","author":"Williams","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0034","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.1833_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(79)91212-4","article-title":"Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers","volume":"5","author":"Boulware","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622025895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622025895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:04:44Z","timestamp":1759745084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622025895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0360301622025895"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.1833","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.1833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}